Talking Guidelines - New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Diseases

In this episode, Prof. Frank Tacke (Charité – Universitätsmedizin Berlin), Prof. Michael Roden (University of Düsseldorf), and Prof. Hannele Yki-Järvinen (University of Helsinki) discuss the groundbreaking new guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD). The episode explores the shift from the term "NASH" to MASLD, addressing the rationale behind this change and its implications for reducing stigma and improving diagnosis. The experts delve into innovative diagnostic tools, such as FIB-4 and transient elastography, and the evolving role of GLP-1 receptor agonists and emerging liver-specific therapies. Join us to learn how multidisciplinary collaboration between hepatologists, diabetologists, and obesity specialists is reshaping the approach to managing liver disease in people with diabetes.